Related Experiment Video

Updated: May 6, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

5.7K

MicroRNA as potential target for gene therapy of multiple myeloma-review

Yan-Jie Li1, Zhen-Yu Li, Kai-Lin Xu

  • 1Laboratory Center of Diagnostics, Xuzhou Medical College, Xuzhou 221002, Jiangsu Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|October 26, 2013
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in multiple myeloma (MM) biology, influencing cancer development and drug resistance. This review explores miRNA signatures, functions, and therapeutic potential in MM.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators of diverse biological processes, including cell differentiation, proliferation, apoptosis, migration, and survival.
  • Aberrant miRNA expression is implicated in the pathogenesis, progression, and metastasis of various malignant tumors.
  • miRNAs can act as oncogenes or tumor suppressors by modulating post-transcriptional gene expression.

Purpose of the Study:

  • To review current advancements on the roles of miRNAs in multiple myeloma (MM) biology.
  • To focus on miRNA signatures associated with MM.
  • To examine the functions of critical miRNAs in MM development and drug resistance.

Main Methods:

  • Literature review of recent studies on miRNA in multiple myeloma.
  • Analysis of miRNA deregulation in MM pathogenesis.
  • Evaluation of miRNA signatures and their functional roles.

Main Results:

  • miRNAs are significantly deregulated in MM, impacting disease mechanisms.
  • Specific miRNA signatures are relevant to MM diagnosis and prognosis.
  • miRNAs play critical roles in MM development, progression, and drug resistance.

Conclusions:

  • miRNAs are vital players in the biology of multiple myeloma.
  • Understanding miRNA deregulation offers insights into MM pathogenesis and drug resistance.
  • miRNA-based therapies hold promise for MM treatment.

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.2K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

563

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
MicroRNAs01:22

MicroRNAs

9.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K